Breast Cancer Canada Funds Survivorship Research Projects
The initiative supports two projects using artificial intelligence to improve care after active cancer treatment.
Updated on Oct. 27, 2026 in Cancer
Live Poll
Is survivorship care for cancer patients getting better or worse in your area?
Breast Cancer Canada and AstraZeneca Canada have awarded $200,000 in research funding to advance breast cancer survivorship care. The investment supports two unique Canadian projects that aim to develop personalized approaches to long-term patient recovery.
Why it matters
The funding addresses significant gaps in post-treatment support for breast cancer survivors across Canada. By leveraging new technology, these initiatives seek to formalize care pathways for patients finishing active therapy.
The funding provides $100,000 to each of the two selected research initiatives. Public opinion data shows 92% of Canadians believe the cancer journey continues after active treatment, while 83% support medically supervised survivorship plans.
The players
Breast Cancer Canada
This national organization is dedicated to funding breast cancer research and providing support to patients and survivors.
AstraZeneca Canada
A pharmaceutical company that collaborates with health organizations to advance medical research and patient care solutions.
Dr. Kamal Haider
An academic lead at the University of Saskatchewan who is directing the SAGE-S research project.
Dr. Amina Silva
A lead researcher based at Brock University who is overseeing an AI-assisted analysis project.
The details
Dr. Kamal Haider leads the SAGE-S project, which uses large language models to assist survivors across Saskatchewan, Alberta, and British Columbia. Meanwhile, Dr. Amina Silva spearheads a project at Brock University that applies AI to analyze experiences shared in online support groups.
Timeline
October 27, 2026: The funding is announced at the ESMO Congress.
October 2026: The research initiatives are highlighted as part of a broader survivorship strategy.
Health Landscape
The projects follow the shift towards patient-centred survivorship care as outlined in the Canadian Cancer Strategy. This research marks a departure from traditional clinical-only focus by integrating AI to address the ongoing needs of cancer survivors.
The research aims to create formal, medically supervised survivorship plans that could eventually become standard for patients post-treatment. These initiatives may improve the quality of care by utilizing AI to better track and support the long-term health needs of survivors.
The takeaway
Breast cancer survivorship is increasingly being recognized as a critical phase that requires dedicated medical oversight beyond primary treatment. Patients are encouraged to discuss post-treatment care plans with their healthcare providers to ensure ongoing monitoring of their recovery.
Further reading
Learn more about the latest research and support initiatives by visiting the Cancer section.
More information
For more information on the research initiatives, visit the Breast Cancer Canada website.
Live Poll
Is survivorship care for cancer patients getting better or worse in your area?
